Who’s The MVP In mRNA?
Messenger RNA (mRNA) has come to the forefront thanks to its role in the Pfizer-BioNTech and Moderna COVID-19 vaccines – and the potential for the… Read More »Who’s The MVP In mRNA?
Messenger RNA (mRNA) has come to the forefront thanks to its role in the Pfizer-BioNTech and Moderna COVID-19 vaccines – and the potential for the… Read More »Who’s The MVP In mRNA?
“Alzheimer’s is the holy grail right now in neurology and diseases of the central nervous system (CNS) because as a form of rapid, non-normal dementia,… Read More »Biotech Stocks To Watch As An Effective Alzheimer’s Treatment Remains Elusive
When it comes to biotech plays, the author of today’s article advises that there are two investors should know: “The first is to buy stock… Read More »2 Biotech Plays To Know – And 1 Stock For Each Play Right Now
While biotech stocks as a whole remain under pressure from interest rate concerns, today’s article highlights three promising small-cap biotech stocks in the neurology space… Read More »3 Promising Small-Cap Biotech Neurology Stocks
Today’s article features two biotech stocks that analysts believe have the potential to double over the next 12 months. The first company is developing therapies… Read More »2 Potential Biotech Doublers
“Remember, no other sector sees stocks move 50% or even more than 100% in a day on a takeover announcement,” notes the author of today’s… Read More »How To Choose Which Biotech Stocks To Pull The Trigger On
As biotech stocks experience a broad correction, the analyst cited in today’s article sees “a number of compelling values” in the space. In particular, he… Read More »Looking For Wins In The Biotech Space
The small-cap biotech featured in today’s article develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and research industries. As… Read More »“Powered By The Pandemic”: An Attractive Entry Point For This Small-Cap Biotech?
When it comes to the best way to gauge biotech stocks ahead of big catalysts, the author of today’s article recommends turning to Wall Street… Read More »Catalysts & Analysts: Why These 2 Biotech Stocks Have Impressive Upside Potential
When it comes to the three biotech stocks featured in today’s article, all of which have experienced recent struggles, the author notes that their management… Read More »These 3 Struggling Biotechs Could Experience Spring Bumps